Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorGarcia Castano, A.
dc.contributor.authorMunoz Couselo, E.
dc.contributor.authorSoria, A.
dc.contributor.authorLavernia, J.
dc.contributor.authorSanmartin, O.
dc.contributor.authorCanueto, J.
dc.contributor.authorAyala de Miguel, P.
dc.contributor.authorBea Ardebol, S.
dc.contributor.authorBellido Hernandez, L.
dc.contributor.authorFernandez-de-Misa Cabrera, R.
dc.contributor.authorCunquero-Tomas, A. J.
dc.contributor.authorFernandez Franco, L.
dc.contributor.authorFernandez-Freire Leal, A.
dc.contributor.authorMujika Eizmendi, K.
dc.contributor.authorOrtiz, C.
dc.contributor.authorRedondo, P.
dc.contributor.authorRomero, I.
dc.contributor.authorSerrano Fernandez, M.
dc.contributor.authorMedina Martinez, J.
dc.contributor.authoraffiliation[Garcia Castano, A.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain
dc.contributor.authoraffiliation[Serrano Fernandez, M.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain
dc.contributor.authoraffiliation[Munoz Couselo, E.] Hosp Valle De Hebron, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Soria, A.] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Lavernia, J.] Fdn Inst Valenciano Oncol IVO, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Sanmartin, O.] Fdn Inst Valenciano Oncol IVO, Dermatol, Valencia, Spain
dc.contributor.authoraffiliation[Canueto, J.] Complejo Asistencial Univ Salamanca, Dermatol, Salamanca, Spain
dc.contributor.authoraffiliation[Ayala de Miguel, P.] Complejo Hospitalario Univ Caceres, Med Oncol, Caceres, Spain
dc.contributor.authoraffiliation[Bea Ardebol, S.] Hosp Univ Ramon y Cajal, Dermatol, Madrid, Spain
dc.contributor.authoraffiliation[Bellido Hernandez, L.] Complejo Asistencial Univ Salamanca, Med Oncol, Salamanca, Spain
dc.contributor.authoraffiliation[Fernandez-de-Misa Cabrera, R.] Hosp Univ Nuestra Senora Candelaria, Dermatol, Santa Cruz De Tenerife, Spain
dc.contributor.authoraffiliation[Cunquero-Tomas, A. J.] Consorcio Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Fernandez Franco, L.] Hosp Virgen Salud, Med Oncol, Toledo, Spain
dc.contributor.authoraffiliation[Medina Martinez, J.] Hosp Virgen Salud, Med Oncol, Toledo, Spain
dc.contributor.authoraffiliation[Fernandez-Freire Leal, A.] Hosp Torrecardenas, Med Oncol, Almeria, Spain
dc.contributor.authoraffiliation[Mujika Eizmendi, K.] UGC Oncol Gipuzkoa OSI Donostialdea Onkol, Med Oncol, Donostia San Sebastian, Spain
dc.contributor.authoraffiliation[Ortiz, C.] Vall dHebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Redondo, P.] Clin Univ Navarra, Dermatol, Pamplona, SpainInst Valenciano Oncol IVO, Med Oncol, Valencia, Spain
dc.contributor.funderSanofi
dc.date.accessioned2025-01-07T12:49:08Z
dc.date.available2025-01-07T12:49:08Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1446
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753421036759/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24953
dc.identifier.wosID700527702079
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Torrecárdenas
dc.organizationSAS - Hospital Universitario Torrecárdenas
dc.page.numberS884-S884
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSafety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files